The goal of the lymphodepletion regimen is to favor the expansion of CAR T-cells following infusion, in vivo expansion, which is probably a critical factor in the clinical efficacy of CAR T-cells. And although the number of regimens may look quite small and the number of drug combinations may look quite small, there are actually significant differences in doses and sequences in the administration of these treatments...
The goal of the lymphodepletion regimen is to favor the expansion of CAR T-cells following infusion, in vivo expansion, which is probably a critical factor in the clinical efficacy of CAR T-cells. And although the number of regimens may look quite small and the number of drug combinations may look quite small, there are actually significant differences in doses and sequences in the administration of these treatments. So understanding what is the optimal dose and the optimal association of these drugs is key, again the key factor in improving CAR T-cell efficiency, and obviously these drugs carry out some significant side effects. So the challenge is to frail people, elderly people, and this is what we are trying to look at in at least one of the GoCART supported projects.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.